General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Eidos, Inc(MODEST), Prothena(MODEST), GSK(MODEST), Novo Nordisk Inc.(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Alnylam Inc(SIGNIFICANT)

View Full Disclosure